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Abstract
Supplementation of direct-fed microbials (DFM) as a means to improve the
health and performance of livestock has generated significant interest over
the past 15+ years. A driving force for this increased interest in DFM is to
reduce or eliminate the use of low-dose antibiotics in livestock production.
This increased attention toward DFM supplementation has generated an
extensive body of research. This effort has resulted in conflicting reports.
Although there has been considerable variation in the design of these stud-
ies, one of the main causes for this lack of consistency may be attributed to
the variation in the experimental immune challenge incorporated to evaluate
DFM supplementation. Taking into account the experimental immune chal-
lenge, there is strong evidence to suggest that DFM supplementation may
have an impact on the immune response, overall health, and performance of
livestock.
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INTRODUCTION
The past 15 years have seen a significant increase in the marketing of direct-fed microbials (DFMs)
to all sectors of livestock agriculture (beef, pork, and poultry). A major reason for this expansion
in DFMs is directed toward replacement of low-dose antibiotics (LDAs). The use of LDAs for
improving animal health in livestock agriculture has been a common practice for over 30 years; the
first documented research trial took place in 1946 (1). LDAs are used to improve the overall health
of livestock. A benefit of this improved health is an increase in body weight (BW) and increased
feed efficiency. However, this production practice has received a great deal of scrutiny owing to
(a) an increase in the number of consumers demanding products produced without LDAs and
(b) increased attention to the issue of antibiotic-resistant bacteria strains in human medicine.
With the increased attention to LDA use in livestock production, a great deal of research has
been devoted to investigating DFMs as a replacement for LDAs. This increased interest in DFMs
has resulted in an enormous amount of research worldwide. In researching this review, we identi-
fied 1,246 scientific articles simply by searching the generic terms “direct-fed microbial,” “perfor-
mance,” “health,” and livestock species. These 1,246 articles were from just 7 highly/moderately
ranked journals (impact factor ≥1.4) in the area of animal agriculture ( Journal of Animal Science,
Journal of Dairy Science, Journal of Poultry Science, Journal of the Science of Food and Agriculture,
Livestock Science, World’s Poultry Science Journal, and Journal of Dairy Research). In addition to these
journals directly related to livestock agriculture and numerous other animal/livestock journals,
several journals in the microbiology field also have published studies related to DFMs. Thus, as a
conservative estimate, there could be well over 3,000 scientific articles regarding the use of DFMs
to enhance livestock production. In such a large, extensive collection of research studies, there
have been conflicting reports. Numerous studies have reported significant benefits for the use of
DFMs (regardless of species), whereas others have reported results that indicate little to no effect.
In this review, we have focused on some of the prevailing research, conflicting data, and future
directions relating to DFM use in the livestock health industry and, particularly, whether DFMs
can adequately substitute for LDAs.
CURRENT DIRECT-FED MICROBIALS
The use of DFMs in livestock has been a research focus for well over 25 years. During this
period, numerous DFMs have been investigated as a means to improve animal health. In 1999,
the official publication of the American Association of Feed Control Officials listed 42 of these
reagents that are accepted as “food” products (i.e., not labeled or promoted with any therapeutic
or structure/function claims). The majority of DFMs that have been investigated are bacteria
(39 different bacteria; see Table 1) (2). However, there have also been numerous studies on
using molds and yeast as DFMs, the majority of which centered around the yeast Saccharomyces
cerevisiae and the mold Aspergillus niger and Aspergillus oryzae (among others). Using just this list,
we identified over 400 scientific studies that directly investigated the use of an “accepted” DFM
in livestock production.
EFFECT OF DIRECT-FED MICROBIALS ON THE IMMUNE
RESPONSE OF LIVESTOCK
Unlike antibiotics (which have either a direct bactericidal or bacteriostatic effect on bacteria),
DFMs must function through indirect mechanisms, such as alterations to the intestinal micro-
biome, enhancement of intestinal efficiency, and modulation of the host innate immune response.
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Table 1 The Association of American Feed Control Officials 1999 official publication list of




The innate immune response is the immunity present in all animals at birth. It consists of rapidly
responding chemical and cellular defense mechanisms (e.g., macrophages, dendritic cells, neu-
trophils, cytokines, and natural killer cells) that need not be induced by prior exposure to an
infectious agent (3). All segments of the livestock industry (cattle, swine, and poultry) have ac-
knowledged the possible health benefits of DFMs. Thus, a major focus of DFM research has been
the impact of specific or multistrain DFMs on innate immune responses of livestock.
When reviewing the literature on the impact of DFMs on animal health, one must also eval-
uate the experimental immune challenge model incorporated to investigate the alterations to
health. In terms of investigating animal health/immune response studies, several models are used:
(a) pathogen challenge, or experimental challenge of live pathogens (bacterial or viral); (b) direct
immune challenge, or experimental challenge with a substance that initiates an immune response
(immunization or endotoxin); and (c) natural exposure, or introduction to an environment similar
to a production setting, in which animals are exposed to pathogens similar to those in the real
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world. Each method is vital for evaluation of animal health and the immune system, and each con-
tributes to our understanding of the impact of DFMs on the immune response. Thus, by taking
into account the method of challenge, we may be able to shed some light on the role of DFMs in
animal health.
Swine
Pathogen challenge. In terms of DFM research for swine, a great deal of attention has been
directed toward enterotoxigenic Escherichia coli (ETEC). ETEC infection causes postweaning
diarrhea, which is one of the most economically devastating diseases afflicting the swine industry
(4). Several researchers have used the ETEC pathogen challenge model to evaluate the response
of DFM supplementation to control diets without LDAs (control−DFM-LDA; Table 2).
Using an ETEC challenge, researchers (5–7) reported that DFM supplementation resulted
in significant alterations in severity and duration of diarrhea in weaned pigs. Pigs supplemented
with S. cerevisiae presented reduced daily diarrhea scores and reduced duration of diarrhea when
compared with control−DFM-LDA pigs (5). Pigs supplemented with Bacillus subtilis were reported
to have fecal scores at both 6 h and 24 h post ETEC challenge that were lower than those
in control−DFM-LDA pigs (6). Furthermore, mortality was decreased in B. subtilis–supplemented
pigs when compared with control−DFM-LDA pigs, and supplementation of Lactobacillus plantarum
appeared to reduce the incidence of diarrhea in pigs, compared with control−DFM-LDA pigs (7).
Researchers have also reported significant alterations to the microbial community of ETEC-
challenged pigs supplemented with a DFM. Supplementation of Pediococcus acidilactici and/or
S. cerevisiae reduced bacterial translocation to the mesenteric lymph nodes when compared with
control−DFM-LDA pigs (8). B. subtilis supplementation resulted in a microbial profile that was richer
and more diverse than that of control−DFM-LDA pigs (6). Supplementation of P. acidilactici or
S. cerevisiae during an ETEC challenge limited the attachment of ETEC F4 to the ileal mucosa
(4). Furthermore, DFM supplementation during an ETEC challenge altered intestinal morphol-
ogy (4). Supplementation of L. plantarum resulted in an increased ileum height and villous/crypt
ratio when compared with control−DFM-LDA pigs (7).
In terms of immune response, ETEC challenge studies have also reported significant alterations
when DFMs were supplemented. Supplementation of L. plantarum resulted in a decrease in the
cytokine tumor necrosis-α (TNFA) and a suggested association for a decrease in pig-major acute
phase protein/ITIH4 (7). P. acidilactici supplementation tended to increase CD8+low T lymphocyte
concentrations in the ileum and CD8+high cells in the mesenteric lymph nodes when compared
with control−DFM-LDA pigs (8). These alterations to lymphocyte subpopulations within the gas-
trointestinal tract could be the result of P. acidilactici stimulation of the local immune system. A
combination of P. acidilactici and S. cerevisiae supplemented to pigs during an ETEC challenge re-
sulted in an increase in interleukin (IL)-6 in ileal tissue when compared with control−DFM-LDA pigs
(4). Supplementation with P. acidilactici alone also indicated a suggested relationship for increasing
IL-6 concentrations compared with control−DFM-LDA pigs (4). There was also a tendency for in-
creased TNFA (TNFRSF1A) expression in P. acidilactici– and S. cerevisiae–supplemented pigs and
increased IL-12p35 (IL-12A) and antimicrobial peptide porcine β-defensin 2 (DEFB1) expression
in P. acidilactici when compared with control−DFM-LDA pigs. There was no effect of treatment on
interferon-γ (IFNG), IL10, or IL8 (4).
Within ETEC challenges, the alterations to animal performance are not as clear due to variation
in experimental design, and in many instances, animal performance was not evaluated/reported.
Supplementation of S. cerevisiae to pigs during an ETEC challenge resulted in an increase in BW
following the challenge compared with control−DFM-LDA pigs (5). However, supplementation of
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PC Neg & Pos + + NR 4
S. cerevisiae Sows = 1 g/kg/diet
Pigs = 1 g/kg/diet to
21 days
Pigs = 5 g/kg/diet to
22–42 days






PC Neg & Pos + NR NI 8
Lactobacillus
plantarum
2 × 1010 CFU/
hd/days
combinationd
PC Neg + NR NI 7
Bacillus subtilis 1.2 × 109 CFU
0.5 g/kg/feed
combinatione
PC Neg & Pos NI + NI 6
S. cerevisiae 182 g/ton/diet DC Neg + + + 10
S. cerevisiae 2 g/kg/diet DC Neg NI NI + 9
Lactobacillus
brevis
5 × 109 CFU/
pig/dayf
NE Neg + + NI 15
Enterococcus
faecium
Sows = 106 g/dietg
Pigs = 105 g/diet
NE Neg NR + NI 13




NE Neg & Pos + NR + 12
S. cerevisiae 0.125% of diet
combinationh







Bolus = 109 CFU/Li
0.05% of diet
combination
NE Neg & Pos NR NR + 14
aChallenge type: DC, direct challenge; NE, natural exposure; PC, pathogen challenge.
bControl used for the studies: Neg, negative control group containing no DFM and no low-dose antibiotics (LDAs); Pos, positive control (provided
LDAs).
cImpact of the study: +, positive impact; NI, no impact; NR, not reported.
dFed as a combination of L. plantarum and lactulose at 15 ml/kg diet.
eFed as a combination of B. subtilis and spray-dried porcine plasma at 1.0 g/kg of diet.
f DFM supplemented via added milk.
gViable cells/g of diet, supplemented for 90 days of gestation and 56 days following parturition.
hDFM supplemented at 0.125% of diet in conjunction with yeast cell wall supplement at 0.2% of diet.
iL. acidophilus and E. faecium were administered as a one-time bolus, whereas B. licheniformis and B. subtilis were supplemented via the diet.
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L. plantarum (7), P. acidilactici and/or S. cerevisiae (8), or B. subtilis (6) did not result in an improve-
ment in animal performance [BW, average daily gain (ADG), gain:feed ratio (G:F), and rate of
diarrhea] during an ETEC challenge.
Direct immune challenge. Although limited, a few studies have evaluated the supplementation
of S. cerevisiae or derivatives of S. cerevisiae. Significant alterations were observed in the immune
response of pigs supplemented DFMs relative to control−DFM-LDA pigs. Although not statistically
significant, there was a tendency (P ≤ 0.09) for supplementation of hydrolyzed yeast (S. cerevisiae)
to increase IgG and IgM antibodies in serum-binding keyhole limpet hemocyanin, suggesting
an activation of the innate immune response; there was no difference in the cytokine pig-major
acute phase protein/ITIH4 (9). Supplementation of live S. cerevisiae to pigs during a lipopolysac-
charide (LPS) challenge reduced peak production of IL1B and IL6, increased peak production
of TNFA, and increased amplitude persistence of IFNG when compared with control−DFM-LDA
pigs (10). There was also a decrease (no statistical information presented) in mortality between
the S. cerevisiae–supplemented pigs when compared with control−DFM-LDA pigs (one pig in the
S. cerevisiae treatment group and four pigs in the control−DFM-LDA treatment group) (10).
Natural exposure. Weaning exposes pigs to multiple stressors (new environment, new cohorts,
new diet, and new pathogens) that can weaken the immune system. Because this transition pe-
riod is a major health hurdle, numerous trials have investigated the role of DFMs as a means to
supplement/boost the immune response and animal performance prior to and/or during weaning.
Again, with numerous trials come conflicting results. Supplementation of S. cerevisiae to newly
weaned pigs for a period of 5 weeks resulted in growth performance (ADG), average daily feed
intake, and G:F similar to that of pigs fed an LDA and greater than that of control−DFM-LDA pigs
(11). Although there were enhancements to animal performance (ADG, average daily feed intake,
and G:F), there was little to no effect on variables of complete blood cell count between the treat-
ments and no difference between the LDA treatment group and controls (11). Supplementation
of the diets with yeast culture containing S. cerevisiae and numerous DFM fermentation prod-
ucts to nursery pigs resulted in ADG similar to that seen with LDA supplementation, and both
were greater than in the control−DFM-LDA pigs, with no impact on immune response (12). Ente-
rococcus faecium supplemented to weaned pigs had no impact on growth performance when com-
pared with control−DFM-LDA pigs (13). There was (though not statistically different) a tendency in
E. faecium–supplemented pigs toward improved G:F and a reduction in overall incidence of di-
arrhea when compared with control−DFM-LDA pigs. Dietary supplementation with Lactobacillus
acidophilus at the time of weaning resulted in no difference in performance when compared to both
the LDA-supplemented pigs and the control−DFM-LDA pigs (14). Supplementation of Lactobacillus
brevis (dam and piglet) during lactation had no effect on weaning performance when compared
with control−DFM-LDA pigs. Aside from performance variables, trials have also reported numerous/
a lack of alterations to the gastrointestinal morphology, intestinal integrity, immune response, and
bacterial community. L. brevis supplementation did decrease E. coli concentrations in the jejunum
when compared with control−DFM-LDA pigs (15), whereas S. cerevisiae supplementation to newly
weaned pigs did not result in alterations to the gastrointestinal morphology or the ileal bacterial
community (11).
Overall, results of the pathogen and endotoxin challenge studies suggest that supplementing
DFMs to pigs can bolster health during the stressful period of weaning (Table 2). These
studies rather consistently indicate that supplementation of DFMs does modulate the immune
response. Whereas there is consistency in the modulation of the immune response, there was an
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enormous amount of variation in the immune system variables analyzed. Regarding the natural
challenge, these studies provide a somewhat more convoluted picture (Table 2). Although there
are conflicting reports, the natural challenge studies do provide some very intriguing results.
Three of the natural exposure studies incorporated a positive control group (supplemented LDA-
supplementation). This allowed for the comparison between DFM and LDA supplementation
(11, 12, 14). Across all three studies, the DFM treatment groups were similar to the positive
control groups. Based upon these results, across the three different challenge models, the data
strongly indicate that DFM supplementation to swine may be a viable replacement for LDAs.
Poultry
The poultry industry has also devoted a great deal of time, energy, and resources to evaluating
the use of DFMs. Thus, a great deal of data related to the impact of DFMs on the innate immune
response in poultry has been reported. The majority of these studies used natural exposure and
pathogen challenge models to define the role of DFMs in poultry; few studies have incorporated
the direct immune challenge model (Table 3).
Pathogen challenge. The majority of the pathogen challenge research in poultry health
has been directed toward avian coccidiosis, which is the major parasitic disease within the
poultry industry, causing reduced growth, reduced egg production, decreased feed efficiency,
and mortality. DFM supplementation has produced consistent results in terms of decreased
fecal shedding of coccidiosis oocysts (Eimeria acervulina or Eimeria tenella). Supplementation
of Lactobacillus-based DFM reduced E. acervulina oocysts following an oral challenge (10,000
and 20,000 sporulated oocysts) (16, 17). Supplementation of P. acidilactici– and S. cerevisiae
boulardii–based DFM reduced E. acervulina or E. tenella oocysts following an oral challenge (5,000
or 10,000 sporulated oocysts) (18, 19). P. acidilactici and S. cerevisiae boulardii supplementation also
resulted in an increase in BW gain when compared with broilers in the control−DFM-LDA group
(19). Also, DFM supplementation during a coccidiosis oral challenge can modulate the immune
response. P. acidilactici– and S. cerevisiae boulardii–based DFM supplemented at a rate of 0.1% of
diet resulted in elevation of antibody response to the recombinant coccidial antigen 3-1E when
compared with a control−DFM-LDA group (18); however, there was no improvement in growth
performance between the groups (17). Supplementation of Lactobacillus-based DFM resulted in
an increase in intestinal intraepithelial lymphocyte expression of surface markers CD3, CD4,
CD8, and αβTCR during a coccidiosis oral challenge when compared with a control−DFM-LDA
group (16). In addition to these alterations, Lactobacillus-based DFM supplementation increased
IFNG (3 days postinfection) and intestinal IL-2 during an E. acervulina challenge when compared
with in control−DFM-LDA chickens, suggesting an enhanced resistance to E. acervulina (17).
Direct immune challenge. DFM supplementation during a direct immune challenge has also
had a significant impact on performance and immune response (Table 3). Supplementation of
Lactobacillus casei, L. acidophilus, or Scytalidium acidophilum during an immunization challenge re-
sulted in improved BW, BW gain, and feed intake (20). L. casei and L. acidophilus supplementation
improved BW and BW gain when compared with control−DFM-LDA and was similar to positive
control containing LDA (20). S. acidophilum supplementation improved BW, BW gain, and feed
intake when compared with a control−DFM-LDA group and was similar to positive control con-
taining antibiotics (20). In terms of the immune response, supplementation of L. casei (inclusion
rate of 425 mg/kg of dry matter in starter diet and 332 mg/kg of dry matter in finisher diet) and
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Lactobacillus 1 g/kg/diet PC Neg + + NR 17



































NI NR + 25
Lactobacillus
Bacillus cereus
DFM 1 × 1012 CFU/
kg/diet
combination of DFM +
ASPd
NE Neg + NR NR 27
Lactobacillus
bulgaricus
20 mg/kg/feed- 2 × 106
40 mg/kg/feed- 4 × 106
60 mg/kg/feed- 6 × 106
80 mg/kg/feed- 8 × 106
NE Neg + NR + 26
S. cerevisiae 2.5 g/kg/feed
5 g/kg/feed
7.5 g/kg/feed
NE Neg + NR + 24
(Continued )
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Table 3 (Continued )
DFM Dosage Challengea
Neg/Pos















0.5 mL bolus 106 NE Neg + NR NR 22
aChallenge type: DC, direct challenge; NE, natural exposure; PC, pathogen challenge.
bControl used for the studies: Neg, negative control group containing no DFM and no low-dose antibiotics (LDAs); Pos, positive control (provided
LDAs).
cImpact of the study: +, positive impact; NI, no impact; NR, not reported.
dAstragalus membranaceus polysaccharide (ASP).
L. acidophilus (inclusion rate of 77 mg/kg of dry matter in starter diet and 62 mg/kg of dry matter
in finisher diet matter) increased KLH-specific antibody concentrations when compared to the
control−DFM-LDA group (20). During a repeated LPS challenge (21), supplementation of a mul-
tistrain DFM was able to lessen the negative impact of LPS-induced anorexia compared with an
LPS-challenged control−DFM-LDA group (21). Although not statistically different, broiler chicks
supplemented with the multistrain DFM had a tendency for increased BW gain and total BW
following the LPS challenge when compared with LPS-challenged control−DFM-LDA chicks (21).
Natural exposure. DFM supplementation also can cause significant alterations to the immune
response in the absence of a controlled immune insult (Table 3). Supplementing chicks with
a three-strain DFM containing L. acidophilus, Bifidobacterium bifidum, and Streptococcus faecalis in-
creased serum and gut antibodies reactive to foreign antigens (tetanus toxoid, α-toxin of Clostridium
perfringens, and bovine serum albumin) (22). Specifically, the three-strain DFM increased serum
IgG and IgM antibodies (reactive to both the foreign antigens tetanus toxoid and α-toxin) when
compared to chicks within the control−DFM-LDA group. Supplementation of a combination of
Lactobacillus reuteri, B. subtilis, and S. cerevisiae to broiler chicks increased white blood cell counts
when compared with both positive control (with LDA) and control−DFM-LDA broiler chicks and in-
creased monocyte concentration when compared with positive control chicks (23). A combination
of the three strains also resulted in increased concentrations of IgA, IgG, and IgM antibodies when
compared with controls, suggesting a possible stimulation of the humoral immune response. The
supplementation of S. cerevisiae and fermentation products to broiler chicks resulted in increased
serum lysozyme content, possibly improving resistance to bacterial infection. Furthermore, sup-
plementation increased antibody titers to Newcastle disease antibodies and IgM antibodies when
compared with control−DFM-LDA broiler chicks, which may be beneficial to the humoral and mu-
cosal immunity (24). Supplementation of Lactobacillus bulgaricus to broiler chicks increased antibod-
ies to Newcastle disease antigen and white blood cells when compared with the control−DFM-LDA
broiler chicks (25). When supplementing broiler chicks with Astragalus membranaceus polysaccha-
ride and a combination of Lactobacillus and Bacillus cereus, there was an increase in Newcastle dis-
ease antibody titer and increased ANAE+ T lymphocytes when compared with control−DFM-LDA
broiler chicks (26). This combination supplementation also resulted in increased immune organ
www.annualreviews.org • DFMs in Livestock Production 343
AV04CH16-Callaway ARI 12 January 2016 14:28
relative weights when compared with the control−DFM-LDA broiler chicks (26). In contrast to these
alterations in IgA, IgG, and IgM, supplementation of a five-strain DFM (L. reuteri, E. faecium,
Bifidobacterium animalis, P. acidilactici, and Lactobacillus salivarius) to broiler chicks did not alter the
concentrations of IgA, IgG, and IgM when compared with control−DFM-LDA broiler chicks (27).
As with the swine DFM studies, the pathogen and direct immune challenge studies provide
rather consistent results in regard to immune response and animal health. All pathogen and
direct immune studies indicated some benefit to DFM supplementation in comparison to the
control−DFM-LDA groups. Regardless of the challenge model, the improvement in animal perfor-
mance was rather mixed; however, some of this could be attributed to several studies not reporting
information related to animal performance (Table 3) (16, 17, 22, 26). For the studies that reported
animal performance, 75% (6 of 8 studies; Table 3) reported that DFM supplementation did re-
sult in an improvement when compared with control−DFM-LDA broilers. Three of the studies used
both a positive and a control−DFM-LDA group; within these studies, there was little to no difference
between DFM-supplemented broilers and the positive control. Overall, the results of the poultry
DFM immune studies are the most convincing in terms of DFM supplementation as a replacement
for LDAs.
Beef
Bovine respiratory disease (BRD) is the most devastating disease facing the beef industry, with an
estimated annual economic impact of ∼$600 million (28). BRD has a multifactorial etiology that
includes stress, viral pathogens, and bacterial pathogens, making it very difficult to combat. The
majority of BRD cases occur during the receiving period at the feedlot. Thus, the main area of
interest for DFMs is during the receiving period. For cattle, the receiving period is the first 28–
56 days at the feedlot. During this time, cattle that have endured the stress of relocation are exposed
to additional stressors, such as comingling with unfamiliar cattle, changes in environment, diet
modification, and exposure to new/novel pathogens. However, unlike in the poultry and pork
industry, no LDAs are used to mitigate the effects of BRD in the beef industry; thus, although
research has been directed at the use of DFMs to improve the health status of cattle during this
feedlot receiving period, this research effort is not as diverse as that for swine and poultry.
Pathogen challenge. In terms of BRD challenges to investigate the role of DFM viability, only
one trial was identified (29). During an infectious bovine respiratory virus challenge, steers sup-
plemented with S. cerevisiae demonstrated an increase in dry matter intake (DMI) on days 3, 10,
and 13 postinfection compared with control steers. This increase resulted in the tendency for
S. cerevisiae–supplemented steers to have less BW loss when compared with the controls (29).
Direct immune challenge. Very few beef cattle trials have incorporated the direct immune
challenge model to evaluate the impact of DFM supplementation on the immune response
of cattle. Although limited in number, these studies have reported significant alterations to
both immune and metabolic responses during a direct immune challenge. Supplementation of
S. cerevisiae to newly received steers results in a modification of metabolism (30). Heifers supple-
mented with S. cerevisiae for a period of 36 days had greater concentrations of insulin, increased
blood urea nitrogen (BUN), and, although not statistically different, a tendency toward decreased
non-esterified fatty acids (NEFA) prior to LPS challenge when compared with control heifers
(2 h prior to LPS challenge). Furthermore, modification of the metabolic response was observed
following the LPS challenge, and heifers provided with the supplement had decreased NEFA
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concentrations and increased BUN concentrations when compared with control heifers (30). In
the same study, researchers also reported a suggested relationship between DFM supplementation
and improved ADG from arrival until LPS challenge when compared with control heifers. In two
similar trials, during an LPS challenge, supplementation of S. cerevisiae to newly received steers
resulted in an increase in glucose and BUN concentrations and decreased NEFA concentrations
compared with controls (31, 32). A few studies have reported the effect of S. cerevisiae supple-
mentation on the innate immune response. Though not statistically significant, it was reported
that supplementation of S. cerevisiae to newly received cattle resulted in a tendency for decreased
sickness scores (33), cortisol (33–35), and white blood cells and lymphocytes (33). In terms of the
proinflammatory cytokines, two trials indicated decreased concentrations of IFNG and TNFA
compared with control cattle (34, 35). However, another trial indicated that supplementation of
S. cerevisiae increased the proinflammatory cytokines TNFA and IFNG compared with control
steers (34). All three trials are fairly similar in design, LPS challenge (source and dose), duration,
and experimental units. However, the possible variation in results could be a result of animal-to-
animal variation, difference in management of cattle prior to the trial, plane of nutrition prior to
the trials, and differences in the specifics and dosage of S. cerevisiae.
Natural exposure. Similar to the direct immune challenge, few DFM studies have investigated
the role of DFMs in improving cattle health during the receiving period (defined as the first
28 days after arrival at the feedlot). Supplementation of a multistrain DFM to newly received steers
during the receiving period had no effect on percentage of steers treated for sickness compared
with control steers (36). Furthermore, DFM supplementation alone did not improve growth
performance. However, there was a connection between DFM supplementation and increasing
concentrations of degradable intake protein (portion of dietary protein that can be degraded
in the rumen by microbial fermentation). As degradable intake protein increased from 80% to
120% of recommended degradable intake protein (10% increments), there was a cubic increase
in ADG. Supplementation of S. cerevisiae to steers upon arrival at the feedlot did not improve the
percentage of cattle identified as morbid but did increase DMI over the 56-day receiving period
when compared with that of controls; there was no difference in BW, ADG, or G:F ratio (35).
In another study, S. cerevisiae supplementation in conjunction with administration of antibiotics
upon arrival at the feedlot did result in decreased rates of cattle treated once or more for BRD
and a decreased odds ratio for “likely to treat” for BRD when compared with control heifers (37).
However, there was no impact of supplementation on DMI, ADG, or G:F when compared with
the control cattle (37). In a three-part study, S. cerevisiae had no impact on morbidity, mortality,
or growth performance when compared with control cattle (29).
The results of the direct immune challenges and the sole pathogen challenges provide strong
evidence that there is some alteration to both the immune and metabolic response of supplemented
cattle when exposed to an immune challenge. These alterations include changes in hormone
concentrations (insulin and cortisol), metabolite concentrations (glucose, BUN, and NEFAs),
proinflammatory cytokines (TNFA, IFNB, and IL-6), and cattle performance (increased DMI
and tendency for decreased BW owing to challenge). However, the data are not nearly as clear in
the studies that used natural exposure. The majority of the natural exposure trials indicated that
DFM supplementation had little to no effect on animal performance and animal health (morbidity
and mortality). Although these natural exposure trials do not provide a clear picture of the role
of DFMs in improving health, there is one major difference between cattle studies and those
performed on swine and poultry: the source of the animals. Unlike swine and poultry studies, in
which all of the animals for the studies originated from a single source (herd) with known genetics,
nutrition, and management background, the cattle used in all of these trials were purchased from
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sale barns or order buyers. Thus, very little is known about the prior management, health, and
genetic background of these cattle. Even the cattle’s chronological age is likely unknown.
UNDERSTANDING THE LACK OF CONSISTENCY IN DIRECT-FED
MICROBIAL TRIALS
So, one must ask, why are there conflicting reports related to DFM supplementations? To explain
this lack of consistency, we must look at LDA function in the gastrointestinal tract (GIT) of
livestock and how this differs from that of DFMs. We must also look at the difference between the
distinct digestive systems represented (monogastric, modified-monogastric, and ruminant). And
finally, we must look directly at the DFM studies and the amount of variation within them.
Livestock agriculture uses LDAs as a means to improve animal health via disease prevention and
treatment. The improvement in animal performance is driven by this improvement in health, as
supplementation of LDAs in a germ-free environment itself does not enhance animal performance
(38, 39). The current explanation for LDA improvement in livestock health is via a direct effect
on the GIT microbiota. This direct interaction with the microbiota is proposed to occur via three
modes of action: (a) prevention of subclinical infection (opportunistic pathogens), (b) retardation
of the production of growth-depressing microbial products, and (c) regulation of microbial use
of nutrients (40). Furthermore, research has also suggested that LDA supplementation enhances
absorption of nutrients (38). This reduction/enhancement of the GIT microbiota and alteration
of the GIT are believed to enhance animal health and performance upon LDA supplementation.
Unlike LDAs, which have a direct impact on the GIT microbiota (antimicrobial or bacterio-
static), DFMs must improve animal health via an indirect modulation. The mode of action for
DFMs includes (a) competitive exclusion, (b) improved digestion and nutrient utilization, (c) im-
munostimulation, and (d ) enhancement of GIT microbiota. Competitive exclusion is defined as
the protective effect of nonpathogenic bacteria limiting the colonization of pathogens. The DFMs
can achieve this competitive exclusion via competitive attachment to the intestinal wall, thereby
preventing colonization by pathogens (41, 42). Supplementation of DFMs may also improve host
digestion. DFMs can provide digestible proteins, enzymes, vitamins, and other important co-
factors to the host GIT. These coproducts can reduce the GIT pH and enhance digestion of
carbohydrates, proteins, and fats (42). Several studies have also reported that supplementation of
DFMs can have a beneficial effect on commensal bacteria within the GIT (43). Supplementation
of a multistrain DFM significantly increased Bifidobacterium spp., Lactobacillus spp., and Gram-
positive cocci counts (27). Given all of these roles, there is strong evidence that DFMs may be an
alternative to LDA supplementation.
There are three unique digestive systems within livestock agriculture: the monogastric (swine),
modified-monogastric (poultry), and ruminant (cattle) systems. Swine are a true monogastric,
with a system similar to the digestive system of humans. Poultry, although classified as a
monogastric, actually have a unique digestive system (modified-monogastric or avian system),
which is drastically different from that of swine. And finally, the ruminant digestive system
is distinct from the monogastric owing to its four-chambered stomach. This four-chambered
stomach allows for the digestion via bacterial fermentation of feedstuffs that are high in cellulose.
With three distinct digestive systems comes a unique and complicated GIT microbiome. With
the recent development of next-generation sequencing, scientists have been able to unlock a
greater part of the microbiome diversity. The swine GIT is a rich microbiome with approximately
1,000 different bacterial species (44). Evaluations of the pig microbiome from two commercial
facilities identified 171 genera from fecal samples (45). Firmicutes and Bacteroidetes phyla
accounted for 90% of the total sequences. Of these 171 genera, 15 represented over 59% of the
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total sequences (Prevotella, Anaerobacter, Streptococcus, Lactobacillus, Coprococcus, Sporacetigenium,
Megasphaera, Subdoligranulum, Blautia, Oscillibacter, Faecalibacterium, Pseudobutyrivifrio, Dialister,
Sarina, and Roseburia). The poultry GIT is also very rich, with over 900 different bacterial
species represented (46). Phylogeneric and statistical analysis of 16S rRNA gene sequences
of the intestinal microbiome has revealed 13 phyla of bacteria; Firmicutes, Bacteroidetes, and
Proteobacteria accounted for 90% of the intestinal bacteria (47). The most prominent genera
identified were Clostridium, Ruminococcus, Lactobacillus, and Bacteroides. The complexity of the swine
and poultry microbiome can be overshadowed by the complexity of the ruminant. The rumen
is a complex microbial ecosystem containing bacteria (∼1010), phages (∼109), protozoa (108),
archaea (∼107), and fungal spores (103) (48, 49). Estimates of microbial species present within the
rumen range from 300–400 (50) to as high as 12,000 (49). Fecal samples for dairy cattle displayed
a large diversity within the bacteria species and genera (51). The prominent genera identified
from all the cattle sampled were Clostridium, Bacteroides, Porphyromonas, Ruminococcus, Alistipes,
Lachnospiraceae–like, Prevotella, Lachnospira, Bacteroidales, Akkermansia, and Enterococcus spp. (51).
Regardless of the species, this microbiome is dynamic, constantly changing in response to age,
exposure to microbes, diet components, and numerous other factors. Furthermore, we are still
trying to unlock the nature of the symbiotic relationship existing between the GIT microbiome
and the host. Research has indicated that the GIT microbiome plays a vital role in nutrient uti-
lization, regardless of the digestive system. Intestinal bacteria are capable of converting otherwise
indigestible polysaccharides, oligosaccharides, and disaccharides into short chain fatty acids via
fermentation of the compositional sugars (52). The microbiome plays an important role in the early
development of the GIT. Broilers raised in a germ-free environment had reduced small intestine
and cecum weights and thinner organ walls when compared with broilers raised in a conventional
system (53, 54). There is also very strong evidence that the microbiome has a significant effect
on immune system development. Mice raised in a germ-free environment exhibited defects in
gut-associated lymphoid tissue (55, 56) and BOX 1 antibody production as well as altered Peyer’s
patches and mesenteric lymph nodes when compared with mice raised in pathogen-free conditions
(57, 58). Also, germ-free animals have impaired development and maturation of isolated lymphoid
follicles, which appear to develop normally when GIT microbes are added (59).
This rich and ever-changing microbiome will be a major component in determining the ef-
ficacy of DFMs. Scientists are just recently starting to gain a better understanding of the role of
the microbiome and its symbiotic relationship with the host animal. As we gain insight into the
relationship between the GIT microbiome and the host, we will be better able to identify and
determine appropriate dosage, route of administration, and duration of supplementation of DFMs.
Aside from the difference between LDAs and DFMs and the diversity of the GIT microbiome,
the other major factor affecting the consistency of DFM research is the variability in the studies
conducted. Within all species, this lack of consistency includes the DFM used, as well as its
administration route, duration, and dosage/concentration. Even within the studies evaluated in
this review, there is an enormous amount of variability in the DFM used (Tables 5–7).
Fourteen trials used a combination (2 DFMs) or a multistrain (3 or more) DFM. The yeast
S. cerevisiae was used in 20 studies, either as the sole DFM or in combination with other
DFMs/coproducts. The most prominent genus of bacteria used was Lactobacillus (used in 11 stud-
ies). For many studies there was also uncertainty as to the specific genus and species of the bacteria
used. Several simply reported a genus, and a few studies mentioned only the trade name of the
DFM (occasionally making it very difficult to identify the specific DFM).
Although the majority of the studies within this review provided the DFMs via feed
(Tables 2–4), there was variability. The method for delivery ranged from supplementation of
the dam with a DFM, direct single-dose administration (oral bolus), direct supplementation via
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PC Neg NR + + 29
S. cerevisiae 0.5 g/hd/day
5.0 g/hd/day
DC Neg + NR NR 34
S. cerevisiae 0.5 g/hd/day
5.0 g/hd/day
DC Neg NR NR + 31
S. cerevisiae 4 g 45 kg/diet DC Neg NR NR + 32





DC Neg NR NR + 34
S. cerevisiae Exp. 1 – mass med.
1 g/hd/day
Exp. 2 – mass med.
1.0 g/hd bolus (one time)
0.5 g/hd/day
Exp. 3 – No mass med.
0.5 g/hd/day
NE Neg NR + NI 37
S. cerevisiae Exp. 1
1010 CFU/g at 5 g/hd/day
combinatione
NE Neg + NR + 35
Exp. 2










80% DIPf + 109 CFU/
hd/day
90% DIP + 109 CFU/
hd/day
100% DIP + 109 CFU/
hd/day
110% DIP + 109 CFU/
hd/day
120% DIP + 109 CFU/
hd/day
NE Neg NR NI + 36










NR NI NI 29
aChallenge type: DC, direct challenge; NE, natural exposure; PC, pathogen challenge.
bControl used for the studies: Neg, negative control group containing no DFM and no low-dose antibiotics (LDAs); Pos, positive control (provided
LDAs).
cImpact of the study: +, positive impact; NI, no impact; NR, not reported.
dProprietary product: Lesaffre Feed Additives.
eCombination treatment included supplementation of S. cerevisiae at 1,010 CFU/g at 5 g/hd/day in addition to 5 g/hd/day of yeast cell wall
supplementation.
f DFM supplementation was evaluated in combination with varying concentrations of digestible intake proteins. For each concentration of degradable
intake protein (DIP) + DFM, there was a control with only elevated concentrations of DIP.
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Table 5 Dosage, duration of direct-fed microbial (DFM) supplementation, age of animals investigated, number of animals
(n), type of immune challenge, and inclusion of negative and/or positive control (Neg/Pos Con) groups of studies














57 1c 80d PC Neg & Pos 4
S. cerevisiae Sows = 1 g/kg/diet
Pigs = 1 g/kg/diet to
21 days
Pigs = 5 g/kg/diet to
22–42 days






42 1 150g PC Neg & Pos 8
Lactobacillus
plantarum
2 × 1010 CFU/hd/day
combinationh
18 25 72 PC Neg 7
Bacillus subtilis 1.2 × 109 CFU
0.5 g/kg/feed
combinationi
14 17 108 PC Neg & Pos 6
S. cerevisiae 182 g/ton/diet 17 25 30 DC Neg 10
S. cerevisiae 2 g/kg/diet 28 25 120 DC Neg 9
Lactobacillus brevis 5 × 109 CFU/pig/dayj 28 1 190 NE Neg 15
Enterococcus faecium Sows = 106 g/dietk
Pigs = 105 g/diet
146 1 17610 NE Neg 13




21 28 192 NE Neg & Pos 12
S. cerevisiae 0.125% of diet
combinationl






Bolus = 109 CFU/Lm
0.05% of diet
combination
34 21 188 NE Neg & Pos 14
aChallenge type: DC, direct challenge; NE, natural exposure; PC, pathogen challenge.
bControl used for the studies: Neg, negative control group containing no DFM and no low-dose antibiotics (LDAs); Pos, positive control (provided
LDAs).
cDFM was supplemented to gilts 28 days prior to parturition, and then supplemented to the pigs until 29 days parturition.
dUsed 40 gilts and then 40 pigs from the litters of the gilts.
eDFM was supplemented to sows 28 days prior to parturition, then supplemented to pigs and sows for 21 days after parturition.
f Used 4 sows and 34 pigs from the 4 litters.
gUsed 30 sows and 120 pigs from the 30 litters.
hFed as a combination of L. plantarum and lactulose at 15 ml/kg/diet.
iFed as a combination of B. subtilis and spray-dried porcine plasma at 1.0 g/kg/diet.
jDFM supplemented via added milk.
kViable cells/g of diet, supplemented for 90 days of gestation and 56 days following parturition.
lDFM supplemented at 0.125% of diet in conjunction with yeast cell wall supplement at 0.2% of diet.
mL. acidophilus and E. faecium were administered as a one-time bolus, whereas B. licheniformis and B. subtilis were supplemented via the diet.
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Table 6 Dosage, duration of direct-fed microbial (DFM) supplementation, age of animals investigated, number of animals
(n), type of immune challenge, and inclusion of negative and/or positive control (Neg/Pos Con) groups of studies













10 1 90 PC Neg 18
P. acidilactici Exp. 1
0.1% of diet
20 1 70 PC Neg 19
S. cerevisiae Exp. 2
0.1% of diet
0.2% of diet
20 1 120 PC Neg
Lactobacillus
Streptococcus
2.1 g/kg/diet 42 1 100 PC Neg 16
Lactobacillus 1 g/kg/diet 33 1 100 PC Neg 17
Lactobacillus casei 75/56 mg/kg/DM (low)
425/332 mg/kg DM (high)
42 1 920 DC Neg + Pos 20
Lactobacillus acidophilus 77/62 mg/kg/DM (low)
457/368 mg/kg/DM (high)















42 1 500 NE Neg & Pos 25
Lactobacillus
Bacillus cereus
DFM 1 × 1012 CFU/
kg/diet
combination of DFM +
ASPc
42 1 240 NE Neg 27
Lactobacillus bulgaricus 20 mg/kg/feed- 2 × 106
40 mg/kg/feed- 4 × 106
60 mg/kg/feed- 6 × 106
80 mg/kg/feed- 8 × 106
36 1 210 NE Neg 26
S. cerevisiae 2.5 g/kg/feed
5 g/kg/feed
7.5 g/kg/feed




0.1% of feed (L. reuteri )
0.1% of feed
(combination)




0.5 mL bolus 106 Not reported 1 14 NE Neg 22
aChallenge type: DC, direct challenge; NE, natural exposure; PC, pathogen challenge.
bControl used for the studies: Neg, negative control group containing no DFM and no low-dose antibiotics (LDAs); Pos, positive control (provided LDAs).
cAstragalus membranaceus polysaccharide (ASP).
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Table 7 Dosage, duration of direct-fed microbial (DFM) supplementation, age of animals investigated, number of animals
(n), type of immune challenge, and inclusion of negative and/or positive control (Neg / Pos Con) groups of studies
investigating the role of DFMs in the health of beef cattle
DFM Dosage
Duration







56 Unknown 24 PC Neg 29
S. cerevisiae 0.5 g/hd/day
5.0 g/hd/day
28 ∼6 months 18 DC Neg 34
S. cerevisiae 0.5 g/hd/day
5.0 g/hd/day
28 ∼6 months 18 DC Neg 31
S. cerevisiae 4 g 45 kg/diet 28 ∼6 months 18 DC Neg 32





36 Unknown 24 DC Neg 34
S. cerevisiae Exp. 1 – mass med.
1 g/hd/day
21 Unknown 81 NE Neg 37
Exp. 2 – mass med.
1.0 g/hd bolus (one time)
0.5 g/hd/day
35 Unknown 277 NE Neg
Exp. 3 – No mass med.
0.5 g/hd/day
35 Unknown 200 NE Neg
S. cerevisiae Exp. 1
1010 CFU/g via 5 g/hd/day
combinationc
56 Unknown 184 NE Neg 35
Exp. 2
1010 CFU/g via 5 g/hd/day
combinationc








80% DIPd + 109 CFU/
hd/day
90% DIP + 109 CFU/
hd/day
100% DIP + 109 CFU/
hd/day
110% DIP + 109 CFU/
hd/day
120% DIP + 109 CFU/
hd/day
56 Unknown 192 NE Neg 36
S. cerevisiae Exp. 1
0.75% of DM





56 Unknown 101 NE Neg
aChallenge type: DC, direct challenge; NE, natural exposure; PC, pathogen challenge.
bProprietary product: Lesaffre Feed Additives.
cCombination treatment included supplementation of S. cerevisiae at 1,010 CFU/g at 5 g/hd/day in addition to 5 g/hd/day of yeast cell wall
supplementation.
dDFM supplementation was evaluated in combination with varying concentrations of digestible intake proteins. For each concentration of DIP + DFM,
there was a control with only elevated concentrations of DIP.
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mixture of diet, and complex combinations of supplementation. There was also variability in the
duration of the DFM being supplemented. Beef cattle studies provided the most consistent time-
frame, with an average length of supplementation of 40 days (minimum = 28 days; maximum =
56 days); this is mainly because the primary period of concern for beef is the receiving period
(the first 28–56 days at the feedlot). The average length of supplementation for poultry trials was
32 days (minimum = 10 days; maximum = 42 days) and for swine was 45 days (minimum =
14 days; maximum = 146 days).
The dosage/concentration of DFMs was also highly variable (Tables 5–7). Within the reviewed
studies, DFM dosage was reported as CFU/head/day, CFU/kg of the diet, DFM g/kg/feed, and
even DFM mg/kg of the diet. Within several studies, the concentration of DFMs was also variable,
with DFMs classified as “low concentrations” and “high concentrations” within the same studies.
There was also a large amount of variability in age at time of supplementation, in the animals
themselves (from those in vertically integrated systems to those purchased at sale barns), and in
variables of interest (primarily in terms of immune response). For the majority of the poultry
studies, animal age was rather consistent, with the majority being within 24 h to 48 h of hatching.
There was a little more inconsistency within the swine studies, with the age of supplementation
ranging from 90 days prior to parturition to 21 days of age (the age at weaning). The cattle had
the greatest age variation at the time of supplementation. Because of the structure of the beef
industry, most of the trials simply identify the gender of the cattle, with no mention of actual age,
and with three independent segments (cow/calf, stocker/backgrounder, and feedlot), the actual
known age of cattle is limited at best. Thus, for the majority of these trials, one can only assume
that the age ranged from 6 to 10 months.
The source and background of the animals used can be a large source of the variability of
DFM trials. For the poultry and swine studies, all animals were sourced from vertically integrated
(commercial or university) systems, in which genetics, nutrition, and management are similar for
all animals studied. However, the beef industry lacks consistency in this regard as well. Most
animals were procured from a sale barn or order buy. Thus, there is little information on genetic
background, prior nutritional status, prior health status, and management prior to arrival (e.g.,
some cattle may have been exposed to a preconditioning program, which includes vaccinations,
whereas others may have received no prior vaccinations). This extreme variability may explain a
great deal of the variation in DFM supplementation when compared with supplementation for
poultry and swine.
The specific parameters that each trial investigated also account for some of the variability
observed. For several studies, the variable of interest was a simple production measurement, such
as animal performance or rate/incidence of diarrhea, morbidity, or mortality. However, other
studies investigated specific aspects of DFM modulation via evaluation of the immune (cytokines,
antibodies, lymphocyte proliferation) and endocrine (cortisol and insulin) systems, direct impact
on metabolic alterations (metabolites), and impact of GIT physiology.
CONCLUSION
There is strong evidence that DFM supplementation can have an impact on the immune response
of livestock (regardless of the species) and potentially improve animal health and performance.
However, we must also realize that no DFM will be a 1:1 replacement for LDAs, and there will be
no one-size-fits-all solution; we must evaluate not only the DFMs but also the best management
practices in conjunction with DFM supplementation. A common statement within most of the
DFM studies is “further research is needed.” This is a very accurate statement, but with one
major caveat: This future research must use a systematic approach that investigates DFMs in
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response to a direct immune challenge and a pathogen challenge, and then, in the natural exposure
environment, must employ consistent dosages, durations, and routes of administration. Once we
have a comprehensive and consistent evaluation of individual DFMs, we will be able to determine
the effect of DFMs as a means to improve animal health.
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